NASDAQ:BSGM BioSig Technologies (BSGM) Stock Price, News & Analysis $0.91 -0.02 (-2.17%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$0.95 +0.04 (+4.86%) As of 02/7/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends About BioSig Technologies Stock (NASDAQ:BSGM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioSig Technologies alerts:Sign Up Key Stats Today's Range$0.90▼$1.0750-Day Range$0.82▼$1.7552-Week Range$0.20▼$2.98Volume243,614 shsAverage Volume130,990 shsMarket Capitalization$15.67 millionP/E RatioN/ADividend YieldN/APrice Target$2.75Consensus RatingBuy Company OverviewBioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.Read More… BioSig Technologies Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks50th Percentile Overall ScoreBSGM MarketRank™: BioSig Technologies scored higher than 50% of companies evaluated by MarketBeat, and ranked 564th out of 951 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingBioSig Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageBioSig Technologies has only been the subject of 1 research reports in the past 90 days.Read more about BioSig Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for BioSig Technologies are expected to grow in the coming year, from ($0.88) to ($0.73) per share.Read more about BioSig Technologies' valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for BSGM. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBioSig Technologies does not currently pay a dividend.Dividend GrowthBioSig Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for BSGM. News and Social Media3.4 / 5News SentimentN/A News SentimentBioSig Technologies has a news sentiment score of 1.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for BioSig Technologies this week, compared to 0 articles on an average week.Search InterestOnly 2 people have searched for BSGM on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat Follows2 people have added BioSig Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, BioSig Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders17.03% of the stock of BioSig Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 7.16% of the stock of BioSig Technologies is held by institutions.Read more about BioSig Technologies' insider trading history. Receive BSGM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address BSGM Stock News HeadlinesReviewing BioSig Technologies (NASDAQ:BSGM) & QT Imaging (NASDAQ:QTI)February 6, 2025 | americanbankingnews.comBioSig Regains Compliance with Nasdaq’s Minimum Bid Price RequirementNovember 14, 2024 | finance.yahoo.comTrump’s $500 Billion AI Move—How You Could ProfitWith Trump's recent AI announcement, a MASSIVE opportunity has opened up for investors. A $500 billion plan is set to reshape America's tech landscape, involving big players like OpenAI, Oracle, and SoftBank. But here's the best part... For as little as $20, you have the opportunity to get in on this revolutionary project... By investing in an under-the-radar company, set to benefit greatly from this massive AI expansion.February 10, 2025 | Behind the Markets (Ad)BioSig Regains Compliance with Nasdaq's Minimum Bid Price RequirementNovember 13, 2024 | globenewswire.comBioSig Technologies to resume trading on Nasdaq following successful appealOctober 23, 2024 | markets.businessinsider.comBioSig Technologies' Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ PanelOctober 22, 2024 | globenewswire.comBioSig Technologies (OTC:BSGM) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comBioSig Technologies (OTC:BSGM) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comSee More Headlines BSGM Stock Analysis - Frequently Asked Questions How have BSGM shares performed this year? BioSig Technologies' stock was trading at $1.49 on January 1st, 2025. Since then, BSGM shares have decreased by 39.0% and is now trading at $0.9088. View the best growth stocks for 2025 here. How were BioSig Technologies' earnings last quarter? BioSig Technologies, Inc. (NASDAQ:BSGM) announced its quarterly earnings data on Thursday, March, 31st. The company reported ($2.40) earnings per share for the quarter, missing the consensus estimate of ($2.20) by $0.20. When did BioSig Technologies' stock split? BioSig Technologies's stock reverse split on Friday, February 2nd 2024. The 1-10 reverse split was announced on Friday, February 2nd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Who are BioSig Technologies' major shareholders? BioSig Technologies' top institutional investors include PFG Investments LLC (0.64%). Insiders that own company stock include Kenneth L Londoner, Steve Chaussy, Patrick Joseph Gallagher, John Sieckhaus and Gray Fleming. View institutional ownership trends. How do I buy shares of BioSig Technologies? Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BioSig Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioSig Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Citius Pharmaceuticals (CTXR), Roku (ROKU) and Ford Motor (F). Company Calendar Last Earnings3/31/2022Today2/09/2025Next Earnings (Estimated)4/15/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:BSGM CUSIPN/A CIK1530766 Webwww.biosig.com Phone(230) 409-5444FaxN/AEmployees50Year FoundedN/APrice Target and Rating Average Stock Price Target$2.75 High Stock Price Target$2.75 Low Stock Price Target$2.75 Potential Upside/Downside+202.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,040,000.00 Net Margins-44,832.50% Pretax Margin-39,405.12% Return on EquityN/A Return on Assets-776.49% Debt Debt-to-Equity RatioN/A Current Ratio0.50 Quick Ratio0.50 Sales & Book Value Annual Sales$20,000.00 Price / Sales783.39 Cash FlowN/A Price / Cash FlowN/A Book Value($0.33) per share Price / Book-2.75Miscellaneous Outstanding Shares17,240,000Free Float14,300,000Market Cap$15.67 million OptionableNo Data Beta0.55 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (NASDAQ:BSGM) was last updated on 2/10/2025 by MarketBeat.com Staff From Our PartnersDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredBig Tech’s $17 Trillion Reckoning DayThe world's biggest tech companies are silently sounding the alarm. While everyday investors keep piling in...InvestorPlace | SponsoredJapanese billionaire pledges $500 billion to Trump’s AmericaJapanese billionaire Masayoshi Son calls it “the beginning of America’s golden age.” But I call it, “you’re...Porter & Company | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Secret Winner in Trump’s AI RevolutionTrump just announced a $500 billion plan to revolutionize artificial intelligence. He's calling it The Star...Behind the Markets | SponsoredTop 5 Trump Stocks for His First 100 DaysRight now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredSteve Bannon Sounds Alarm On Elon Musk’s ‘Indefensible Betrayal’Now, if Elon Musk was truly an America First champion… His cronies wouldn't be bragging to the New York Tim...Colonial Metals | SponsoredElon’s ‘Agents’ StrikeHe might be the richest man on the planet – but Elon Musk just landed himself a new job... In a move that c...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.